These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 21351337)
1. Unique gene-silencing and structural properties of 2'-fluoro-modified siRNAs. Manoharan M; Akinc A; Pandey RK; Qin J; Hadwiger P; John M; Mills K; Charisse K; Maier MA; Nechev L; Greene EM; Pallan PS; Rozners E; Rajeev KG; Egli M Angew Chem Int Ed Engl; 2011 Mar; 50(10):2284-8. PubMed ID: 21351337 [No Abstract] [Full Text] [Related]
2. Modified siRNAs for the study of the PAZ domain. Somoza A; Terrazas M; Eritja R Chem Commun (Camb); 2010 Jun; 46(24):4270-2. PubMed ID: 20485810 [TBL] [Abstract][Full Text] [Related]
3. Contributions of 3'-overhang to the dissociation of small interfering RNAs from the PAZ domain: molecular dynamics simulation study. Lee HS; Lee SN; Joo CH; Lee H; Lee HS; Yoon SY; Kim YK; Choe H J Mol Graph Model; 2007 Mar; 25(6):784-93. PubMed ID: 16959510 [TBL] [Abstract][Full Text] [Related]
4. 5΄-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo. Haraszti RA; Roux L; Coles AH; Turanov AA; Alterman JF; Echeverria D; Godinho BMDC; Aronin N; Khvorova A Nucleic Acids Res; 2017 Jul; 45(13):7581-7592. PubMed ID: 28591791 [TBL] [Abstract][Full Text] [Related]
5. New opportunities for designing effective small interfering RNAs. Valdés JJ; Miller AD Sci Rep; 2019 Nov; 9(1):16146. PubMed ID: 31695077 [TBL] [Abstract][Full Text] [Related]
6. Unexpected origins of the enhanced pairing affinity of 2'-fluoro-modified RNA. Pallan PS; Greene EM; Jicman PA; Pandey RK; Manoharan M; Rozners E; Egli M Nucleic Acids Res; 2011 Apr; 39(8):3482-95. PubMed ID: 21183463 [TBL] [Abstract][Full Text] [Related]
7. Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme. Li F; Pallan PS; Maier MA; Rajeev KG; Mathieu SL; Kreutz C; Fan Y; Sanghvi J; Micura R; Rozners E; Manoharan M; Egli M Nucleic Acids Res; 2007; 35(19):6424-38. PubMed ID: 17881374 [TBL] [Abstract][Full Text] [Related]
8. Structural insights into RISC assembly facilitated by dsRNA-binding domains of human RNA helicase A (DHX9). Fu Q; Yuan YA Nucleic Acids Res; 2013 Mar; 41(5):3457-70. PubMed ID: 23361462 [TBL] [Abstract][Full Text] [Related]
9. Chemical modification of siRNA. Chernolovskaya EL; Zenkova MA Curr Opin Mol Ther; 2010 Apr; 12(2):158-67. PubMed ID: 20373259 [TBL] [Abstract][Full Text] [Related]
10. Expanding the Scope of 2'-SCF3 Modified RNA. Jud L; Košutić M; Schwarz V; Hartl M; Kreutz C; Bister K; Micura R Chemistry; 2015 Jul; 21(29):10400-7. PubMed ID: 26074479 [TBL] [Abstract][Full Text] [Related]
11. Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook. Shukla S; Sumaria CS; Pradeepkumar PI ChemMedChem; 2010 Mar; 5(3):328-49. PubMed ID: 20043313 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and properties of 4'-C-aminoalkyl-2'-fluoro-modified RNA oligomers. Kano T; Katsuragi Y; Maeda Y; Ueno Y Bioorg Med Chem; 2018 Aug; 26(15):4574-4582. PubMed ID: 30097362 [TBL] [Abstract][Full Text] [Related]
13. The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes. Song JJ; Liu J; Tolia NH; Schneiderman J; Smith SK; Martienssen RA; Hannon GJ; Joshua-Tor L Nat Struct Biol; 2003 Dec; 10(12):1026-32. PubMed ID: 14625589 [TBL] [Abstract][Full Text] [Related]
14. Potent and systematic RNAi mediated silencing with single oligonucleotide compounds. Lapierre J; Salomon W; Cardia J; Bulock K; Lam JT; Stanney WJ; Ford G; Smith-Anzures B; Woolf T; Kamens J; Khvorova A; Samarsky D RNA; 2011 Jun; 17(6):1032-7. PubMed ID: 21493786 [TBL] [Abstract][Full Text] [Related]
15. Nucleic acid 3'-end recognition by the Argonaute2 PAZ domain. Lingel A; Simon B; Izaurralde E; Sattler M Nat Struct Mol Biol; 2004 Jun; 11(6):576-7. PubMed ID: 15156196 [TBL] [Abstract][Full Text] [Related]